Digital Library
Close Browse articles from a journal
     Journal description
       All volumes of the corresponding journal
         All issues of the corresponding volume
                                       All articles of the corresponding issues
 
                             25 results found
no title author magazine year volume issue page(s) type
1 Algeria's response to COVID-19: an ongoing journey Klouche-Djedid, Selma Nihel

9 5 p. 449
article
2 Bronchial thermoplasty: 10 years and counting Langton, David

9 5 p. 436-437
article
3 Confronting COVID-19-associated cough and the post-COVID syndrome: role of viral neurotropism, neuroinflammation, and neuroimmune responses Song, Woo-Jung

9 5 p. 533-544
article
4 Correction to Lancet Respir Med 2021; published online March 26. https://doi.org/10.1016/S2213-2600(21)00169-7
9 5 p. e49
article
5 Could a good night's sleep improve COVID-19 vaccine efficacy? Benedict, Christian

9 5 p. 447-448
article
6 COVID-19 severity and obesity: are MAIT cells a factor? McCarthy, Cormac

9 5 p. 445-447
article
7 COVID-19 vaccination in athletes: ready, set, go… Hull, James H

9 5 p. 455-456
article
8 Early outcomes after lung transplantation for severe COVID-19: a series of the first consecutive cases from four countries Bharat, Ankit

9 5 p. 487-497
article
9 European guideline on managing adults in hospital with COVID-19 Venkatesan, Priya

9 5 p. e50
article
10 IL-6 blockade for COVID-19: a global scientific call to arms Murthy, Srinivas

9 5 p. 438-440
article
11 Into the abyss Bigham, Blair

9 5 p. 452-453
article
12 Major differences in ICU admissions during the first and second COVID-19 wave in Germany Karagiannidis, Christian

9 5 p. e47-e48
article
13 Neutrophilic asthma: misconception or misnomer? Nair, Parameswaran

9 5 p. 441-443
article
14 Pandemic fans the flames of smoking and health inequity The Lancet Respiratory Medicine,

9 5 p. 435
article
15 Peginterferon lambda for the treatment of outpatients with COVID-19: a phase 2, placebo-controlled randomised trial Feld, Jordan J

9 5 p. 498-510
article
16 Pembrolizumab with or without radiotherapy for metastatic non-small-cell lung cancer: a pooled analysis of two randomised trials Theelen, Willemijn S M E

9 5 p. 467-475
article
17 Pirfenidone in patients with non-IPF progressive fibrotic interstitial lung diseases: expert guidance is urgently needed Wells, Athol U

9 5 p. 437-438
article
18 Pirfenidone in patients with progressive fibrotic interstitial lung diseases other than idiopathic pulmonary fibrosis (RELIEF): a double-blind, randomised, placebo-controlled, phase 2b trial Behr, Jürgen

9 5 p. 476-486
article
19 Safety and effectiveness of bronchial thermoplasty after 10 years in patients with persistent asthma (BT10+): a follow-up of three randomised controlled trials Chaudhuri, Rekha

9 5 p. 457-466
article
20 Sarilumab in patients admitted to hospital with severe or critical COVID-19: a randomised, double-blind, placebo-controlled, phase 3 trial Lescure, François-Xavier

9 5 p. 522-532
article
21 Separation—a letter to my child Goh, Orlanda

9 5 p. 450-451
article
22 The Troublemaker Paul, Trisha K

9 5 p. 451-452
article
23 Tocilizumab plus standard care versus standard care in patients in India with moderate to severe COVID-19-associated cytokine release syndrome (COVINTOC): an open-label, multicentre, randomised, controlled, phase 3 trial Soin, Arvinder S

9 5 p. 511-521
article
24 Treatment of mild-to-moderate asthma in childhood and adolescence in 2021 Abrams, Elissa M

9 5 p. 443-445
article
25 Young person with long COVID after mild disease Kirby, Tony

9 5 p. 453-455
article
                             25 results found
 
 Koninklijke Bibliotheek - National Library of the Netherlands